← Insider buys
KRTX

Karuna Therapeutics, Inc.

Director Atul Pande sold $529K of Karuna Therapeutics, Inc.

Sold$529,345
$92.64Price
5,714Shares
−100%Stake

What KRTX did after the filing

Prices for KRTX after this filing aren't in yet.

Traded Mon, Dec 14. Filed Mon, Dec 14, 5:10 PM ET, after the close. Not investment advice.